Find clinical trials for Breast Cancer in Los Angeles, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Los Angeles, CA, USA:
The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer and triple ne ...
Phase 1
Los Angeles, California, United States and 8 other locations
(ICI) on on 3-year Event Free Survival (EFS), in women with residual hormone receptor negative, HER2-negative ("triple negative") resectable breast...
Phase 2
Los Angeles, California, United States and 3 other locations
This trial is a Phase 2 neoadjuvant study evaluating ARV-471 or anastrozole in post-menopausal women with ER+/HER2- localized breast cancer...
Phase 2
Los Angeles, California, United States and 48 other locations
to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...
Phase 2
Duarte, California, United States and 10 other locations
This trial will evaluate the use of immunotherapy and PARP inhibition in a population with incurable advanced breast cancer associa ...
Phase 2
Los Angeles, California, United States
A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...
Phase 1
Santa Monica, California, United States and 8 other locations
To evaluate the efficacy of cryoablation without lumpectomy and its impact on local and distant recurrence of early stage breast cancer...
Santa Ana, California, United States and 18 other locations
in combination with either of two chemotherapy regimens (weekly paclitaxel or capecitabine) in unresectable/metastatic triple negative breast...
Phase 1, Phase 2
Los Angeles, California, United States and 1 other location
of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, stage II-III, Estrogen Receptor positive, HER-2 negative breast...
Phase 2
Los Angeles, California, United States and 14 other locations
This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...
Phase 3
Los Angeles, California, United States and 226 other locations
Clinical trials
Research sites
Resources
Legal